Table 2 The hazard ratio and incidence for comparing matched intellectual disability disorder (IDD) and non-IDD group for the primary composite outcome and its constituents
Outcome | Incidence of post-COVID-19 condition (%) | Hazard ratio | (95%CI) | P value* | |
|---|---|---|---|---|---|
IDD group | Non-IDD group | ||||
Chest/throat pain: | 3.21% | 2.73% | 1.148 | (0.998, 1.320) | 0.053 |
Abnormal breathing | 4.41% | 3.33% | 1.216 | (1.077, 1.373) | 0.002 |
Abdominal symptoms | 5.42% | 4.06% | 1.259 | (1.128, 1.406) | < .0001 |
Fatigue: | 3.62% | 2.50% | 1.397 | (1.216, 1.606) | < .0001 |
Anxiety/Depression | 6.59% | 5.53% | 1.157 | (1.050, 1.274) | 0.003 |
Headache | 3.39% | 2.57% | 1.260 | (1.097, 1.448) | < .0001 |
Cognitive symptoms | 2.61% | 1.28% | 1.828 | (1.529, 2.186) | < .0001 |
Myalgia | 1.58% | 0.98% | 1.325 | (1.077, 1.631) | 0.008 |
Loss of taste/smell | 0.01% | 0.02% | 0.304 | (0.061, 1.506) | 0.122 |
Sleep disturbance | 1.11% | 0.74% | 1.481 | (1.148, 1.910) | 0.002 |
Cough | 3.59% | 2.54% | 1.315 | (1.146, 1.508) | < .0001 |
Palpitation | 1.36% | 1.29% | 1.104 | (0.893, 1.365) | 0.362 |
Any post-COVID-19 condition | 15.82% | 13.99% | 1.120 | (1.053, 1.191) | < .0001 |